Directorate Change
November 05 2003 - 1:30AM
UK Regulatory
RNS Number:6827R
Biotrace International PLC
05 November 2003
For Immediate Release: Wednesday 5th November 2003
BIOTRACE INTERNATIONAL PLC
Appointment of New Non-Executive Director
Biotrace International Plc, a leading manufacturer and provider of industrial
microbiology products and related services, is pleased to announce that
following a Board meeting yesterday Dr. Atholl Turrell was appointed to the
Board of Biotrace as a Non-Executive Director with immediate effect.
Dr. Turrell (aged 49) spent his early career as an academic prior to joining
Peat Marwick Mitchell & Co in 1981. He qualified as a Chartered Accountant in
1984 and left in 1985 to pursue a career in investment banking initially with
Charterhouse Bank and then with Merrill Lynch, Deutsche Bank and Schroder
Salomon Smith Barney. Dr. Turrell is Vice-Chairman of Arbuthnot Securities
Limited.
Dr. Turrell will chair the Audit Committee and will become a member of the
Remuneration Committee.
There are no details regarding Dr. Turrell that require disclosure under section
6. F. 2 (b) to (g) referred to in paragraph 16.4 of the Listing Rules.
- ENDS -
For further information, please contact:
Biotrace International Plc Tel: +44 (0) 1656 641 400
Ian Johnson, Chief Executive
Peter Morgan, Finance Director
Buchanan Communications Tel: +44 (0) 20 7466 5000
Tim Anderson / James Strong
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAUSABROBRARAA